lobbying_activities: 539878

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
539878	fdd1543d-af24-486f-be6f-7dcc6a295ef0	Y@	ML STRATEGIES, LLC	25603	NOVARTIS PHARMACEUTICALS	2007	year_end	HCR	S 484, Enhancing Drug Safety and Innovation Act of 2007, Title 1, drug safety; and Title 3, clinical trials registry and results. Federal Food, Drug and Cosmetic Act (21 USC 301), Chapters 1-9 as they relate to the review, approval and regulation of drugs biologics and devices.	HOUSE OF REPRESENTATIVES,SENATE	100000		0	0	2007-12-05T15:07:11-05:00